Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
Allergy & Immunology
Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
